Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
The FDA just approved the first size-adjustable pulmonary valve replacement for children with congenital heart disease. The Autus Size-Adjustable Valve (Edwards Lifesciences) can expand as a child grows, potentially reducing the need for repeat open-heart surgeries. It's also the first FDA-approved heart valve made with polymeric — rather than animal-derived — leaflets.
For kids born with congenital heart disease, timing a pulmonary valve replacement has always been a high-stakes decision — act too early and the child may need multiple open-heart surgeries as they grow; wait too long and you risk serious harm. The FDA just approved a device designed to change that calculus.
The Autus Size-Adjustable Valve (Edwards Lifesciences) is the first pulmonary valve replacement that can be implanted in children and then expanded over time via a minimally invasive balloon dilation procedure — no additional open-heart surgery required. It's also a materials first: the valve uses polymeric leaflets instead of the animal-derived tissue found in all previously approved heart valves.
By the Numbers:
Why it matters: Fewer repeat surgeries means less trauma, faster recovery, and a better quality of life for young patients and their families. Longer-term studies are ongoing to confirm durability as more children grow into — and beyond — the device's expandable range.
